Taiwan Lawmakers Say Government Favors Pharmas In Flu Crisis
This article was originally published in PharmAsia News
Executive SummaryTaiwan legislators accused the nation's health authorities of giving in to pharmaceutical companies and allowing sharp increases in flu antivirals. They said the sharp increases occurred after it was announced the National Health Insurance would cover the cost of prescriptions for Roche's Tamiflu (oseltamivir). Legislators said that following the announcement, the price of the drug increased by 18 percent. One lawmaker said the spike in the price amounts to nearly $23 million for the government. An NHI official said the threat of a pandemic has raised the market price of the drug significantly. (Click here for more
You may also be interested in...
Steve Niedelman of the law firm King & Spalding gave manufacturers a few words of advice when prepping their so-called front rooms, where US FDA investigators do the majority of their work during facility inspections. See what he said here.
The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”